Cargando…

Incorporating future unrelated medical costs in cost-effectiveness analysis in China

The occurrence of future unrelated medical costs is a direct consequence of life-prolonging interventions, but most pharmacoeconomic guidelines recommend the exclusion of these costs. The Chinese guidelines were updated in 2020, taking an exclusion approach for the future unrelated medical cost. We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Shan, Wang, Yitong, Zhou, Junwen, Jiang, Yawen, Liu, Gordon G, Wu, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549663/ https://www.ncbi.nlm.nih.gov/pubmed/34702751 http://dx.doi.org/10.1136/bmjgh-2021-006655

Ejemplares similares

Incorporating productivity loss in health economic evaluations: a review of guidelines and practices worldwide for research agenda in China
por: Jiang, Shan, et al.
Publicado: (2022)

Cost-effectiveness analysis of ranibizumab for retinal vein occlusion patients in China from the societal perspective
por: Ni, Weiyi, et al.
Publicado: (2021)

Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life
por: Cai, Dan, et al.
Publicado: (2021)

Direct Medical Costs of Incident Complications in Patients Newly Diagnosed With Type 2 Diabetes in China
por: He, Xiaoning, et al.
Publicado: (2020)

Estimating comparable English healthcare costs for multiple diseases and unrelated future costs for use in health and public health economic modelling
por: Briggs, Adam D. M., et al.
Publicado: (2018)

Health care resource utilization and direct medical costs for patients with schizophrenia initiating treatment with atypical versus typical antipsychotics in Tianjin, China
por: He, Xiaoning, et al.
Publicado: (2015)

Time to incorporate time in cost-effectiveness analysis
por: van de Wetering, Gijs, et al.
Publicado: (2012)

Health Insurance Coverage and Its Impact on Medical Cost: Observations from the Floating Population in China
por: Zhao, Yinjun, et al.
Publicado: (2014)

Future costs in cost-effectiveness analysis: an empirical assessment
por: Kruse, Marie, et al.
Publicado: (2010)

The cost-effectiveness of conducting three versus two reverse transcription-polymerase chain reaction tests for diagnosing and discharging people with COVID-19: evidence from the epidemic in Wuhan, China
por: Jiang, Yawen, et al.
Publicado: (2020)

Quality of life and cost consequence of delays in endovascular treatment for acute ischemic stroke in China
por: Ni, Weiyi, et al.
Publicado: (2022)

Memory for Semantically Related and Unrelated Declarative Information: The Benefit of Sleep, the Cost of Wake
por: Payne, Jessica D., et al.
Publicado: (2012)

Reciprocal cooperation between unrelated rats depends on cost to donor and benefit to recipient
por: Schneeberger, Karin, et al.
Publicado: (2012)

Taking stock of cost-effectiveness analysis of healthcare in China
por: Butt, Thomas, et al.
Publicado: (2019)

Future Costs in Cost-Effectiveness Analyses: Past, Present, Future
por: de Vries, Linda M., et al.
Publicado: (2018)

The cost-effectiveness analysis of the New Rural Cooperative Medical Scheme in China
por: Wu, Jinjing, et al.
Publicado: (2018)

Incorporating health and ecologic costs into agricultural production.
por: Fenske, Richard A
Publicado: (2002)

Priority setting: the importance of incorporating opportunity costs
por: Norheim, Ole Frithjof
Publicado: (2012)

Impact of assumptions on future costs, disutility and mortality in cost-effectiveness analysis; a model exploration
por: Omidvari, Amir-Houshang, et al.
Publicado: (2021)

Prediction of Future Medical Costs by Modifiable Measures of Health
por: Haji-Sheikhi, Farnoosh, et al.
Publicado: (2023)

Future medical and non-medical costs and their impact on the cost-effectiveness of life-prolonging interventions: a comparison of five European countries
por: Mokri, Hamraz, et al.
Publicado: (2022)

Cost Saving or Cost Effective? Unanswered Questions in the Screening of Patients With Nonalcoholic Fatty Liver Disease
por: Jiang, Z. Gordon, et al.
Publicado: (2019)

A Cost-Utility Analysis of Lung Cancer Screening and the Additional Benefits of Incorporating Smoking Cessation Interventions
por: Villanti, Andrea C., et al.
Publicado: (2013)

Incorporating statistical uncertainty in the use of physician cost profiles
por: Adams, John L, et al.
Publicado: (2010)

Feasibility analysis of incorporating infertility into medical insurance in China
por: Wang, Lin, et al.
Publicado: (2022)

Actuarial Cost Analysis for options on the Future of the Fund
Publicado: (2016)

Daily Costs and Cost Effectiveness of Glaucoma Fixed Combinations in China
por: Xu, Chenjia, et al.
Publicado: (2020)

Cost-effectiveness and value-based prices of the 9-valent human papillomavirus vaccine for the prevention of cervical cancer in China: an economic modelling analysis
por: Jiang, Y, et al.
Publicado: (2019)

The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study
por: Gu, Dongfeng, et al.
Publicado: (2015)

Incorporation of genetic model parameters for cost-effective designs of genetic association studies using DNA pooling
por: Ji, Fei, et al.
Publicado: (2007)

Cost-utility analysis of lurasidone for the first-line treatment of schizophrenia in China
por: Liu, Jia, et al.
Publicado: (2022)

Cost-effectiveness analysis of treatment timing considering the future entry of lower-cost generics for hepatitis C
por: Heath, Katherine
Publicado: (2018)

Medical Service Utilization and Direct Medical Cost of Stroke in Urban China
por: Zhu, Dawei, et al.
Publicado: (2020)

Direct medical costs of hospitalized patients with idiopathic pulmonary fibrosis in a tertiary hospital in China
por: Zheng, Xiao-Fen, et al.
Publicado: (2020)

Incidence and risk factors of medical complications and direct medical costs after osteoporotic fracture among patients in China
por: Liu, Ruiqi, et al.
Publicado: (2018)

Gamification of Hospital Utilization: Incorporating Cost-consciousness in Daily Practices
por: Tomaselli, Peter J, et al.
Publicado: (2018)

Cost-Free LTC Model Incorporated into Private Pension Schemes
por: De La Peña, J. Iñaki, et al.
Publicado: (2021)

Cost-effectiveness analysis of vaccination against COVID-19 in China
por: Zhou, Huixuan, et al.
Publicado: (2023)

Medical resource utilization and the associated costs of asthma in China: a 1-year retrospective study
por: Yang, Xueer, et al.
Publicado: (2023)

Addressing methodological and ethical issues in practicing health economic evaluation in China
por: Jiang, Shan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uocli16qhevv8qjlg2p4tl6e9i